Bicycle Therapeutics Ltd (BCYC) — Cash Flow-to-Debt Ratio
Bicycle Therapeutics Ltd (BCYC) has a Cash Flow-to-Debt Ratio of -0.49x as of September 2025, meaning its operating cash flow of $-71.17 Million could theoretically repay 0% of its total liabilities ($145.47 Million) in one year. See Bicycle Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bicycle Therapeutics Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Bicycle Therapeutics Ltd across 9 annual periods. Also explore Bicycle Therapeutics Ltd (BCYC) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bicycle Therapeutics Ltd (2016–2024)
Year-by-year debt coverage analysis for Bicycle Therapeutics Ltd. For market capitalisation and broader financial context, see BCYC market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.01x | $-164.72 Million | $163.81 Million | ▼ -272.2% |
| 2023 | -0.27x | $-60.63 Million | $224.41 Million | ▲ +56.1% |
| 2022 | -0.62x | $-86.11 Million | $139.83 Million | ▼ -455.9% |
| 2021 | -0.11x | $-14.79 Million | $133.54 Million | ▲ +59.1% |
| 2020 | -0.27x | $-17.79 Million | $65.69 Million | ▲ +83.9% |
| 2019 | -1.68x | $-28.61 Million | $17.00 Million | ▼ -877.7% |
| 2018 | -0.17x | $-26.08 Million | $151.45 Million | ▼ -1374.7% |
| 2017 | -0.01x | $-1.42 Million | $121.19 Million | ▲ +99.6% |
| 2016 | -2.96x | $-11.27 Million | $3.81 Million | — |